Investigates renal autoregulation and blood‑flow dynamics in conscious preclinical models to illuminate CKD and hypertension. Combines telemetry, ultrasound, and time‑series machine learning to quantify injury risk, sex differences, and genetic modifiers for translational biomarkers and therapy testing.